By SPC News Staff
A new study shows that two kidney transplant patients treated with immunosuppressive drugs, and who later had a lengthy COVID-19 infection, developed a version of the virus with a mutation that made it resistant to the antiviral therapy remdesivir (Veklury, Gilead).
A new study, led by researchers at NYU Grossman School of Medicine and NYU Long Island School of Medicine, shows that two kidney transplant patients treated with immunosuppressive drugs, and who later had a lengthy